Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.4278
-0.0291 (-6.37%)
At close: Mar 28, 2025, 4:00 PM
0.4301
+0.0023 (0.54%)
Pre-market: Mar 31, 2025, 8:22 AM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $28.67 million as of March 31, 2025. Its market cap has decreased by -85.63% in one year.
Market Cap
28.67M
Enterprise Value
-63.00M
1-Year Change
-85.63%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $28.67M, a decrease of -97.32%. That is a compound annual growth rate of -53.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 28.67M | -59.51% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |